In addition, consistent with other studies [18, 19, 21], our data suggest that neither AID nor isolated ABF significantly influence the course of MS, as we found no clear differences between the groups regarding MS relapse or disease progression measured by the EDSS. Here, AICDA is linked to myeloid sarcoma.